Most recent update: Monday, October 15, 2018 - 17:33

Bariatric News - Cookies & privacy policy

- News

Adolescents undergoing Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) experienced the greatest decline in BMI and in large part maintained this weight loss over the five-year follow-up time period, while patients undergoing adjustable... (more)

15/10/18 - News

Obalon Therapeutics has gained approval of a Premarket Approval Supplement (PMA-S) application for the Obalon Touch Inflation System, an automated system utilized to inflate the Obalon Balloon, from the FDA. The Obalon Touch is intended to be commercialised in combination with... (more)
15/10/18 - News

Women who are overweight or have obesity have up to twice the risk of developing colorectal cancer (CRC) before age 50 as women who have what is considered a ‘normal’ BMI, according to new research led by Washington University School of Medicine in St Louis.
14/10/18 - News

GI Dynamics has announced the selection of Intertek as the company’s notified body to continue working toward re-attaining the CE Mark for its EndoBarrier product, an endoscopically delivered device therapy for the treatment of type 2 diabetes and obesity. GI Dynamics selected... (more)



Laparoscopic sleeve gastrectomy (LSG) has lower overall complications rate, fewer minor post-operative complications and better short- and medium-...

13/10/18 - News

LNC Therapeutics, a French biotech company specialized in the gut microbiome-based drug discovery, has announced the launch of a new clinical trial with Stablor, OBEMINALE 2, and the treatment of the first patient. This new clinical study is intended to obtain 13.5 health claim... (more)
12/10/18 - News

Researchers from the US and Switzerland have reported the outcomes from a large study examining new ways to measure obesity. The study looked at both the metabolome and the genome, and their relationship to BMI, and who is at an elevated risk of developing obesity-related... (more)
11/10/18 - News

According to a new national survey conducted by NORC at the University of Chicago and sponsored by Ethicon, more than one-third have experienced fat shaming or weight bias either personally or through someone they know. The nationally representative survey findings were released... (more)

More news

11/10/18 - Research
Amino acids and metabolism
Type 2 diabetes is driven by many metabolic pathways, with some pathways driven by amino acids, the molecular building blocks for proteins. Scientists at Joslin Diabetes Center now have shown that one amino acid, alanine, may produce a short-term lowering of glucose levels by altering energy... (more)
11/10/18 - Research
Life expectancy and obesity
Young adults with obese in Australia can expect to lose up to ten years in life expectancy, according to a major study from The George Institute for Global Health and the University of Sydney, which also predicted that 36.3 million years of life will be lost over the lifetime of today's Australian... (more)
10/10/18 - Research
Adolescence weight gain
Weight gain between the age of 10 and adulthood is associated with type 2 diabetes (T2D) risk that is independent of BMI, according to research presented at this year's annual meeting of the European Association for the Study of Diabetes (EASD) in Berlin, Germany. Furthermore, children who are... (more)
10/10/18 - Research
Resectional OAGB-MGB
Resectional One Anastomosis Gastric Bypass/Mini Gastric Bypass (R-OAGB/MGB) is a viable option for revisional bariatric procedures and could - in the future - be considered as a primary bariatric procedure considering its technical aspects and the potential advantage on weight loss, according to... (more)
10/10/18 - Research
Gene mutation
Researchers at Harvard Medical School and Brigham and Women's Hospital have discovered a gene mutation that slows the metabolism of sugar in the gut, giving people who have the mutation a distinct advantage over those who do not. Those with the mutation have a lower risk of diabetes, obesity, heart... (more)
09/10/18 - Research
CALIBER clinical trial
The results of the CALIBER clinical trial has revealed that Linx Reflux Management System was significantly more effective in relieving symptoms and improving quality of life gastrointestinal reflux disease (GERD) than taking twice-daily acid suppression drugs. The Linx Reflux Management System is... (more)